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Abstract
Background: Although oral cavity squamous cell carcinoma is a major health problem in India, oral cavity non-Hodgkin’s
lymphoma (NHL) is very rare. The diagnosis of oral lymphomas may be challenging because frequently there is a low index
of clinical suspicion, leading to misdiagnosis and/or delayed treatment.
Aims andObjectives: To analyze clinicopathological aspects of patients with NHL of the oral cavity diagnosed at our
institute.
Materials andMethods: This was a retrospective observational study. We included consecutive patients who were
diagnosed with oral cavity NHL at our institute over the past 10 years.
Results: Nine patients (six men and three women) were diagnosed with primary NHL of the oral cavity at our institute in the
past 10 years. Oral tongue was the most common site followed by alveolus. All patients had presented with gradually
increasing ulcerative mass in the oral cavity. None of the patients had B symptoms. Plasmablastic lymphoma was the most
common type of NHL followed by diffuse large B-cell lymphoma.
Conclusion: Involvement of the oral cavity by lymphoma is rare. Plasmablastic lymphoma was the most common oral
cavity NHL in our patients.
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Introduction
The oral cavity consists of the lips, ﬂoor of mouth, oral
tongue (the anterior two thirds of the tongue), buccal mucosa,
upper and lower gingiva, hard palate, and retromolar trigone.
In India, according to the GLOBOCAN 2012 data, oral cavity
squamous cell carcinoma was the most common cancer in
men accounting for 53,842 cases (11.3% of all cancer cases),
and it was the third most common cause of cancer-related
deaths after lung and stomach cancer. In women, oral cavity
cancer stood ﬁfth in terms of incidence and cancer-related
mortality following breast, cervix, colorectal, and ovarian
cancer.[1]
Oral cavity mass can be the rare presentation of a number
of conditions, including infections such as bacterial osteomyelitis,
invasive fungal infection, and syphilis; inﬂammatory diseases
particularly Wegener’s granulomatosis; and neoplasms parti-
cularly non-Hodgkin’s lymphoma (NHL).[2] Diagnosing the
underlying cause requires consideration of several factors as
well as gram stain, fungal stain, culture, and histopathologic
examination of biopsy specimen and immunohistochemistry
studies.[2]
Involvement of the oral cavity by NHL is very rare. The oral
cavity constitutes only 2% of all extranodal lymphomas.[3]
There is paucity of literature regarding clinicopathological
aspects of the oral cavity NHL because of the rarity of this
entity. We herein present the clinicopathological aspects of
nine cases of primary extranodal lymphomas of the oral cavity
diagnosed at our institute.
Materials andMethods
This was a retrospective analysis of patients who
presented with oral mass and on evaluation were diagnosed
with primary NHL of the oral cavity at our institute. The study
included patients who were diagnosed between 2002 and
2012. The case ﬁles of individual patients were analyzed for
information regarding age and gender, presenting features,
site of involvement in the oral cavity, immunohistochemistry
report, and retroviral positivity status.
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Results
A total of nine patients (six men and three women) were
diagnosed with primary NHL of the oral cavity in the past 10
years. The median age at presentation was 45.2 years (range
29–65 years). The sites of involvement in the oral cavity were
oral tongue in ﬁve patients, alveolus in two, gingivobuccal
sulcus in one, and hard palate in one. All the patients
presented with gradually increasing ulcerative mass in the
oral cavity. None of the patients had B symptoms. All the
patients had aggressive NHL. Five patients were diagnosed
with plasmablastic lymphoma. Three patients had diffuse large
B-cell lymphoma (DLBCL). One patient was diagnosed to
have peripheral T-cell lymphoma, not otherwise speciﬁed
(PTCL, NOS) of the hard palate. On serological testing, three
patients were found to be HIV positive. All of them had
plasmablastic lymphoma (two of oral tongue and the other one
of alveolus) (Table 1).
Discussion
The incidence of oral cancer is high in India due to high
prevalence of tobacco addiction either in the form of smoked
tobacco (bidi, cigarette, chillum, hookah) or in the form of
smokeless tobacco (gutkha, khaini, paan masala). Almost
95% of the oral cavity tumors are squamous cell carcinomas.
Primary extranodal lymphoma of the oral cavity is very rare.
Oral cavity constitutes only 2% of all extranodal lymphomas.[3]
The diagnosis of oral lymphomas may be challenging because
frequently there is a low index of clinical suspicion, leading to
misdiagnosis and/or delayed treatment.
In Western literature the median age of patients with NHL
of the oral cavity is 59 years (range 3–88 years), and men are
more commonly affected than women.[4] In one of the Indian
studies, the median age of patients with primary extranodal
NHL of the oral cavity was reported to be 46.2 years with M/F
ratio of 3:2.[5] In our study, the median age was found to be
44.2 years (range 29–65 years) with a male preponderance
(six men and three women).
van der Waal et al.[4] have mentioned palate and gingiva as
the most common sites for lymphomas of the oral cavity. In the
study of Shah et al.[5], gingivobuccal complex was the most
common site in 12 of 15 patients. In our study, oral tongue was
the most common site of lymphoma of the oral cavity.
In the oral cavity, lymphoma usually presents as an
extranodal, soft-elastic, asymptomatic lesion.[6] However, all
our patients were symptomatic with gradually increasing
ulcerative mass in the oral cavity. Most NHLs of the head
and neck do not have ‘‘B’’ symptoms.[4] However, Enrique
et al.[7] noted B symptoms in 27% patients with NHL of the
head and neck in his series of 31 cases. In this study, none of
the patients had B symptoms, and all the patients had
presented with gradually increasing ulcerative mass in the
oral cavity.
In immunocompetent individuals, the most common
lymphoma in the head and neck region is DLBCL subtype,
although other subtypes of lymphoma such as mantle cell
lymphoma, marginal zone B-cell lymphoma, Burkitt’s lymphoma,
lymphoblastic lymphoma, PTCL, and anaplastic large cell
lymphoma can also occur.[8] In this study, three of the six
immunocompetent patients had DLBCL. According to Teruya-
Feldstein et al.[9], the most common histological subtype found
in immunocompromised individuals is plasmablastic variety.
In this study, three patients were found to be HIV positive; all of
them had plasmablastic lymphoma (two of oral tongue and
one of alveolus).
In our study, plasmablastic lymphoma was the most
common lymphoma of the oral cavity. Median age at
presentation of plasmablastic lymphoma was around 50 years,
and plasmablastic lymphoma was most frequently present as
mass in the oral cavity but other extranodal involvement was
also seen such as paranasal sinus, orbit, skin, bone, soft tissues,
and gastrointestinal tract.[10] Immunophenotypic plasmablastic
cells are positive for CD138, CD38, and MUM1. Leukocyte
common antigen and CD20 positivity uniformly seen in DLBCL
Table 1: Patient characteristics
Age (years) M/F Site IHC report Diagnosis
26 M RT gingivobuccal sulcus LCA+, CD138+, CK–, CD20- ,CD 30-, HMB- Plasmablastic lymphoma
55 M Oral tongue CD20+, LCA+,CD30–, HMB–, CD3- DLBCL
35 F Alveolus LCA+, CD138+, CK–, CD20-, CD30- Plasmablastic lymphoma
55 M Oral tongue LCA+, CD138+, CD20-, CD30-, CD3-, CD7- Plasmablastic lymphoma
58 M Oral tongue LCA+, CD138+, CK–, CD20-, CD30-, HMB- Plasmablastic lymphoma
65 F Alveolus CD20+, LCA+, CK-, CD30–, HMB–, CD3- DLBCL
49 F Oral tongue LCA+, CD138+, CK–, CD20-, CD30-, HMB- Plasmablastic lymphoma
29 M Oral tongue CD20+, LCA+, CK-, CD30-, HMB–, CD3- DLBCL
35 M Hard palate CD3+, CD5+, Bcl2+, CD20-, CD10-, EMA-, ALK- PTCL,NOS
ALK, anaplastic lymphoma kinase; ART, antiretroviral therapy; CK, cytokeratin; CR, complete remission; CT, chemotherapy; DLBCL, diffuse large
B-cell lymphoma; DF, disease free; EBRT, external beam radiotherapy; ECOG, Eastern Cooperative Oncology Group; EMA, epithelial membrane
antigen; HMB, human melanoma black; LCA, leukocyte common antigen; PS, performance status; PTCL, NOS, peripheral T-cell lymphoma, not
otherwise speciﬁed; RT, radiotherapy.
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cases is usually weak to scant in PBL. Cytoplasmic
immunoglobulin, most frequently IgG and either kappa or
lambda light chain expression, is seen in 50–70% of cases.
Expression of epithelial membrane antigen and CD30 are
frequently seen. Ki-67 index is usually very high (490%).
In our study, ﬁve patients were diagnosed with plasma-
blastic lymphoma. In all of them, CD 138 was positive and
Ki-67 index was very high (490%). (Panels 1 and 2 show
microscopic and immunohistochemistry features of DLBCL
and plasmablastic lymphoma.)
Conclusion
Although prevalence of carcinoma of the oral cavity is very
high in our country, the incidence of primary extranodal NHL
is very rare. High index suspicion is required for diagnosis of
this rare disease as delayed diagnosis ultimately affects the
prognosis. Plasmablastic lymphoma was the most common
NHL of the oral cavity in our patients.
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Figure 1: (A) Squamous epithelium of the oral cavity with malignant
lymphoid cells in subepithelium (H&E,100 low power). (B) Large
neoplastic lymphoid cells with prominent nucleoli (H&E, 450 high
power). (C) CD20 positivity (IHC–HRP polymerase,100). (D) LCA
positivity (IHC–HRP polymerase, 100).
Figure 2: Plasmablastic lymphoma: (A) Squamous epithelium of the
oral cavity with malignant lymphoid cells in subepithelium (H&E,100
low power). (B) Malignant cells with tingible body macrophages (H&E,
450 high power). (C) CD138 positive cells (IHC–HRP polymerase,
100). (D) Kappa positive cells (IHC–HRP polymerase, 100).
(E) MUM1 positive cells on IHC. (F) Ki-67 high proliferative index
490%,100.
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